Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
WARREN, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN), today provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™.
Tevogen.AI™ aims to integrate advanced machine learning and predictive modeling into Tevogen Bio's proprietary ExacTcell™ technology to significantly enhance its target identification and pre-clinical processes, thereby strengthening the Company's pipeline of innovative immunotherapies, accelerating clinical timelines, and substantially reducing development costs.
Tevogen.AI currently has two proprietary technologies, each with patents pending, and an internal valuation of these assets is forthcoming. The Company plans to expand its AI initiative with applications that extend well beyond Tevogen Bio. In preparation for this anticipated growth, Tevogen is expanding its headquarters to include dedicated facilities for Tevogen.AI's team of data scientists and engineers.
Tevogen CEO, Dr. Ryan Saadi, commented, 'Healthcare is one of the largest segments of our economy, projected to approach $5 trillion in the U.S. in 2025 and a significant contributor to our rising national debt. Tevogen.AI's vision extends beyond transforming how therapies are developed; it is expected to make a meaningful impact across multiple sectors of healthcare. I applaud the leadership team at Tevogen.AI and our strategic partners for their innovative efforts and contributions that will help define the future of healthcare.'
Strategic Partnerships:
Microsoft (Nasdaq: ): Provides industry-leading AI expertise, cloud computing infrastructure (Azure), and scientific resources to accelerate drug discovery processes.
Databricks: Supplies specialized data engineering and analytics capabilities to refine Tevogen's AI models and enhance predictive accuracy.
Proprietary Tevogen.AI Technology:
PredicTcell™: AI tools capable of accurately predicting immunologically active peptide complexes and their interactions with T cell receptors, driving precision in immunotherapy treatments.
The PredicTcell platform is a collection of multiple algorithms which performs in-silico predictions for candidate selection across multiple diseases. It continually improves with each accurate prediction through model tuning and reinforcement, helping expand our understanding of T cell receptor bindings, and therefore shortening the in-vivo process and expanding Tevogen Bio's pipeline. To date, Tevogen.AI has developed a continually expanding, terabyte-scale database that processes millions of protein and peptide interactions spanning numerous diseases and the human genome.
AdapTcell™: Algorithms to decode the interactions between human leukocyte antigens (HLA) and T cells.
AdapTcell is expected to significantly enhance Tevogen Bio's understanding of immune responses and open new therapeutic avenues, especially in areas with minimal existing data. As our understanding of key interactions expand, AdapTcell built algorithms perform experiments unlocking insights into genetics and proteomics. The platform aims to expand upon the cross sections of genetics and protein interactions and build an HLA specificity map.
Tevogen.AI plans to expand into clinical trial patient identification using the information collected from its PredicTcell and AdapTcell platforms to drive efficiency, cost reduction and deliver targeted results.
Tevogen remains committed to transparent communication with its stockholders and will continue providing clear updates on the progress and achievements of Tevogen.AI.
Forward Looking Statements
This press release contains certain forward-looking statements, including without limitation statements relating to: Tevogen's plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen's development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'possible,' 'potential,' 'goal,' 'opportunity,' 'project,' 'believe,' 'future,' and similar words and expressions or their opposites. These statements are based on management's expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company's control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements.
Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen's commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen's limited operating history; and those factors discussed or incorporated by reference in Tevogen's Annual Report on Form 10-K.
You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law.
Contacts
Tevogen Bio Communications
T: 1 877 TEVOGEN, Ext 701
Communications@Tevogen.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
CSCO Q1 Earnings Call: AI Demand and New Partnerships Drive Strategic Shift
Networking technology giant Cisco (NASDAQ:CSCO) missed Wall Street's revenue expectations in Q1 CY2025, but sales rose 11.4% year on year to $14.15 billion. Its non-GAAP EPS of $0.96 per share was 4.6% above analysts' consensus estimates. Is now the time to buy CSCO? Find out in our full research report (it's free). Revenue: $14.15 billion (11.4% year-on-year growth) Adjusted EPS: $0.96 vs analyst estimates of $0.92 (4.6% beat) Revenue Guidance for Q2 CY2025 is $14.6 billion at the midpoint, roughly in line with what analysts were expecting Management raised its full-year Adjusted EPS guidance to $3.78 at the midpoint, a 1.9% increase Operating Margin: 22.6%, up from 17.2% in the same quarter last year Annual Recurring Revenue: $30.6 billion at quarter end, up 4.8% year on year Billings: $14.26 billion at quarter end, up 5.5% year on year Market Capitalization: $254.9 billion Cisco's first quarter highlighted significant momentum in its AI and networking businesses, fueled by double-digit growth in product orders and strong performance in key segments like enterprise routing and campus switching. CEO Chuck Robbins emphasized the impact of accelerated product innovation and the company's ability to deliver large-scale AI infrastructure, noting, 'We received AI infrastructure orders from web-scale customers in excess of $600 million in Q1, bringing our year-to-date total to well over $1 billion.' Management credited the quarter's growth to robust demand across web-scale, enterprise, and public sector customers, as well as ongoing adoption of new products like WiFi 7 and industrial IoT offerings. Additionally, the integration of Splunk contributed to security segment growth, with notable wins in the financial services sector. Looking ahead, Cisco's leadership pointed to a multi-year runway for AI-related demand and expansion into sovereign cloud opportunities as key drivers of its forward guidance. Robbins outlined the importance of partnerships, such as the recent collaboration with NVIDIA and new initiatives in the Middle East, stating, 'We believe the AI opportunity for us is a strong one…we play across the full stack.' CFO Scott Herren highlighted ongoing tariff uncertainty and the impact of supply chain agility on gross margins, while also noting that the ramp-up of enterprise AI deployments and new product launches are expected to support revenue and margin performance. Management's outlook is shaped by expectations of continued demand for AI infrastructure, heightened security needs, and the transition to more recurring, software-driven revenue streams. Cisco's first quarter results were shaped by heightened demand for AI infrastructure, progress in security and software, and the continued shift toward recurring revenue. Management also discussed organizational changes and new strategic partnerships. AI infrastructure order momentum: Cisco surpassed its annual AI order target early, with over $600 million in web-scale AI infrastructure orders during the quarter. Management attributed this to strong demand from large data center customers and emphasized that these orders are non-linear, depending on customer deployment schedules and Cisco's delivery capacity. Security segment acceleration: The integration of Splunk drove high double-digit growth in security orders, highlighted by a major multi-year deal with a financial services customer. Cisco's new security products, including Secure Access, XDR, and Hypershield, collectively added over 370 new customers, with many bundling security directly into network hardware. Recurring revenue focus: The company reported steady gains in annual recurring revenue and product ARR, with subscription revenue now comprising more than half of total revenue. This ongoing transition to software and services is intended to improve business predictability and resilience. Product innovation pipeline: Cisco announced several advancements, including the launch of a quantum network prototype and new AI-driven security solutions. The company also highlighted its partnership with NVIDIA to create unified network architectures for AI workloads, aiming to simplify deployment and enhance security for enterprise customers. Leadership changes: CFO Scott Herren announced his retirement, with Chief Strategy Officer Mark Patterson set to take over. Jeetu Patel was promoted to President and Chief Product Officer, reflecting a renewed focus on product strategy and accelerated innovation. Additionally, Kevin Weil, Chief Product Officer of OpenAI, joined the board of directors. Cisco expects future performance to be driven by sustained AI infrastructure investment, an expanding partner ecosystem, and increased focus on software-based solutions. Ongoing AI demand: Management believes that the global expansion of AI, including sovereign cloud initiatives and enterprise AI deployments, will provide a multi-year growth opportunity. Cisco anticipates demand from both web-scale and enterprise customers as AI applications require advanced networking and security. Supply chain and tariff management: The company faces ongoing uncertainty around tariffs, particularly after the July 9 pause ends. Cisco's ability to leverage its supply chain scale and flexibility is expected to mitigate some cost pressures, though management cautions that tariffs could impact gross margins in the near term. Recurring revenue and new solutions: Cisco is prioritizing the growth of its subscription-based offerings and accelerating the rollout of new products, such as the WiFi 7 portfolio and AI-powered security tools. These initiatives are intended to drive more predictable revenue streams and capitalize on evolving customer needs. Looking forward, the StockStory team will be monitoring (1) the pace at which AI infrastructure orders convert into revenue, (2) execution on new partnerships and sovereign cloud deals such as the HUMAIN initiative, and (3) the rollout and adoption rates for Cisco's latest security and networking products. Progress on recurring revenue growth and the impact of tariff changes on margins will also be important indicators to watch. Cisco currently trades at a forward P/E ratio of 16.5×. At this valuation, is it a buy or sell post earnings? The answer lies in our full research report (it's free). Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25 minutes ago
- Yahoo
Tri Counties Bank Announces Business and Commercial Banking Expansion
CHICO, Calif., June 04, 2025--(BUSINESS WIRE)--Tri Counties Bank has restructured its business and commercial management teams to provide more specialized expertise and superior service for California businesses. This move strengthens Tri Counties Bank's ability to better serve businesses of all sizes with streamlined access to specialized lending, helping businesses scale faster, navigate market fluctuations, and seize growth opportunities. The restructuring ensures businesses receive tailored financial solutions at every stage of growth: Business Banking, for businesses between $2 million and $10 million in revenue Commercial Banking, for businesses between $10 million and $50 million in revenue Middle Market and Specialty Banking, for businesses with annual revenues greater than $50 million Scott Myers, Head of Wholesale Banking at Tri Counties Bank, led the strategic reorganization of the business banking divisions, bringing more than 25 years of experience to reshape how California businesses receive financial services. "Tri Counties Bank is uniquely positioned to serve the diverse needs of businesses of all sizes across California," Myers said. "Our goal is to continue to deliver upon our successful service model of true relationship-based banking." This restructuring directly reflects the needs of businesses throughout California that value relationship-based banking with experts who can tailor products to fit their unique needs. Tri Counties Bank appointed senior leaders with vast experience to oversee specialized industry-focused teams: Aytom Salomon, Managing Director of Middle Market and Specialty Banking Lindsey Fudge, Managing Director of Middle Market Commercial Real Estate Vanessa Ryan, Director of Public Sector Banking Brett Lew, Director of Food and Agribusiness Banking Businesses interested in learning more about how these new specialized services can support their financial growth can visit or call 1-800-982-2660. About Tri Counties Bank Established in 1975, Tri Counties Bank is a wholly-owned subsidiary of TriCo Bancshares (NASDAQ: TCBK), headquartered in Chico, California with corporate offices in Roseville, South San Francisco, and Bakersfield, with assets of nearly $10 billion and 50 years of financial stability. Tri Counties Bank is dedicated to providing exceptional service for individuals and businesses throughout California with more than 75 locations, advanced mobile and online banking, and access to approximately 40,000 surcharge-free ATMs nationwide. As California's Local Bank, Tri Counties Bank prioritizes serving clients with local bankers and local decision-making, backed by corporate philanthropy, community engagement, employee volunteerism and investments. Recognized by various publications as among the Top Workplaces and Best Banks, Tri Counties Bank recruits and retains diverse and talented team members. Visit to learn more. Member FDIC. Equal Housing Lender. NMLS #458732. View source version on Contacts Megan Sheehan, AVP, Public Relations ManagerMeganSheehan@ (530) 332-2330
Yahoo
25 minutes ago
- Yahoo
Trump promises to hike steel and aluminum tariffs to 50%
Markets on Wall Street inched up quietly early Wednesday as President Donald Trump's 50% tariffs on imports of steel and aluminum were due to kick in and U.S and European trade officials met in Paris to negotiate their tariff spat. Futures for the S&P 500, the Dow Jones Industrial Average and Nasdaq all rose 0.2% in light trading before the bell. The European Union's top trade negotiator, Maroš Šefčovič, met Wednesday with his American counterpart, U.S. Trade Representative Jamieson Greer, on the sidelines of a meeting of the Organisation for Economic Cooperation and Development. Šefčovič said talks were 'advancing in the right direction at pace.' Few expect Brussels and Washington to reach a substantive trade agreement in Paris because the issues dividing them are too difficult to resolve quickly. There has been no official update on the status of the steel and aluminum tariffs as of early Wednesday morning. Those tariffs are expected to hit a broad range of businesses hard and likely push up prices for consumers. Foreign-made steel and aluminum is used in household products like soup cans and paper clips as well as big-ticket items like a stainless-steel refrigerators and cars. Economists warn that the latest tariffs will significantly squeeze the wallets of both companies and shoppers alike. Hopes remain high on Wall Street that Trump will reach trade deals with other countries that will ultimately lower tariffs, particularly with the world's second-largest economy. The U.S. side said Trump was expecting to speak with Chinese leader Xi Jinping this week. In equities trading, Wells Fargo rose 2.5% after the Federal Reserve lifted its asset cap on Tuesday and said the bank is no longer subject to the harsh restraints placed on it in 2018 for having a toxic sales and banking culture. Wells has spent the better part of a decade trying to restore its image with the public and convince policymakers that it had changed its ways. Shares of Dollar Tree dipped 1.8% before the bell despite Wednesday's strong first-quarter sales and profit report. Investors were spooked by the discount retailer's forecast, which estimated as much as a 50% drop in second-quarter earnings per share due to cost pressures from higher tariffs. A day earlier, rival Dollar General posted a quarterly sales record of $10.44 billion and upgraded its annual profit and sales outlook as Americans tighten their budgets and spend more at bargain stores. CrowdStrike, the cybersecurity company that Delta Air Lines has sued for a technology outage last summer, fell 7% after it issued lighter second-quarter guidance than analysts were expecting. Elsewhere, in Europe at midday, Germany's DAX and the CAC 40 in Paris each gained 0.7%, while Britain's FTSE 100 inched up 0.2%. South Korea's Kospi led gains in Asia, jumping 2.7% to 2,770.84 after the liberal opposition candidate Lee Jae-myung was elected president. Lee's victory caps months of political turmoil triggered by the stunning but brief imposition of martial law by the now-ousted conservative leader Yoon Suk Yeol. Top priorities will include government spending and trade negotiations with the United States. Tokyo's Nikkei 225 index surged 0.8% to 37,747.45 on gains for technology and pharmaceutical companies. Toyota Motor Corp.'s shares rose 1.9% after it announced it was buying Toyota Industries Corp., a maker of auto parts and lift trucks, for $33 billion and taking it private. Toyota Industries' shares tumbled nearly 12%. Chinese shares were modestly higher. The Hang Seng in Hong Kong added 0.6% to 23,654.03, while the Shanghai Composite index gained 0.4% to 3,376.20. In Australia, the S&P/ASX 200 closed 0.9% higher at 8,541.80. Taiwan's Taiex climbed 2.3%. Treasury yields held relatively steady following Tuesday's encouraging report on the U.S. job market. It's a cooldown from a sharp rise for yields over the last two months. Yields had been climbing in part on worries about how the U.S. government may be set to add trillions of dollars to its debt through tax cuts. Higher Treasury yields make it more expensive for U.S. households and businesses to borrow money and can discourage investors from paying high prices for stocks and other investments. In energy trading, U.S. benchmark crude oil added 3 cent to $63.44 per barrel. Brent crude, the international standard, rose 5 cents to $65.68 per barrel. The U.S. dollar rose to 144.19 Japanese yen from 144 yen. The euro rose to $1.1386 from $1.1370. Download the and apps to get breaking news and weather alerts. Watch or with the new . Follow us on social media: Close Thanks for signing up! Watch for us in your inbox. Subscribe Now Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
